Compartmentation of cAMP signalling in cardiomyocytes in health and disease

Acta Physiologica

Volumn 207, Issue 4, 2013, Pages 650-662

  Perera, R K ^a   Nikolaev, V O ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

3 ,5 cyclic adenosine monophosphate; A kinase anchoring protein; Cardiomyocyte; Compartmentation; F rster resonance energy transfer; Phosphodiestarase

Indexed keywords

CYCLIC AMP; IC86340; PROTEIN INHIBITOR; UNCLASSIFIED DRUG;

APOPTOSIS; BIOLUMINESCENCE RESONANCE ENERGY TRANSFER; CELL COMPARTMENTALIZATION; FLUORESCENCE RESONANCE ENERGY TRANSFER; HEART DISEASE; HEART FAILURE; HEART MUSCLE CELL; HUMAN; INTRACELLULAR SIGNALING; LONG QT SYNDROME; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW;

ANIMALS; CYCLIC AMP; DISEASE MODELS, ANIMAL; HEART; HEART DISEASES; HUMANS; MICE; MYOCARDIUM; MYOCYTES, CARDIAC; SECOND MESSENGER SYSTEMS; SIGNAL TRANSDUCTION;

EID: 84874714962     PISSN: 17481708     EISSN: 17481716     Source Type: Journal    
DOI: 10.1111/apha.12077     Document Type: Review

References (119)

1. Abi-Gerges, A., Richter, W., Lefebvre, F., Mateo, P., Varin, A., Heymes, C., Samuel, J.L., Lugnier, C., Conti, M., Fischmeister, R. & Vandecasteele, G. 2009. Decreased expression and activity of cAMP phosphodiesterases in cardiac hypertrophy and its impact on beta-adrenergic cAMP signals. Circ Res 105, 784-792.
2. Adams, S.R., Harootunian, A.T., Buechler, Y.J., Taylor, S.S. & Tsien, R.Y. 1991. Fluorescence ratio imaging of cyclic AMP in single cells. Nature 349, 694-697.
3. Altarejos, J.Y. & Montminy, M. 2011. CREB and the CRTC co-activators: sensors for hormonal and metabolic signals. Nat Rev Mol Cell Biol 12, 141-151.
4. Beca, S., Helli, P.B., Simpson, J.A., Zhao, D., Farman, G.P., Jones, P.P., Tian, X., Wilson, L.S., Ahmad, F., Chen, S.R., Movsesian, M.A., Manganiello, V., Maurice, D.H., Conti, M. & Backx, P.H. 2011. Phosphodiesterase 4D regulates baseline sarcoplasmic reticulum Ca2+ release and cardiac contractility, independently of L-type Ca2+ current. Circ Res 109, 1024-1030.
5. Bernstein, D., Fajardo, G., Zhao, M., Urashima, T., Powers, J., Berry, G. & Kobilka, B.K. 2005. Differential cardioprotective/cardiotoxic effects mediated by beta-adrenergic receptor subtypes. Am J Physiol Heart Circ Physiol 289, H2441-H2449.
6. Berthouze, M., Laurent, A.C., Breckler, M. & Lezoualc'h, F. 2011. New perspectives in cAMP-signaling modulation. Curr Heart Fail Rep 8, 159-167.
7. Bittar, G. & Friedman, H.S. 1991. The arrhythmogenicity of theophylline. A multivariate analysis of clinical determinants. Chest 99, 1415-1420.
8. Bodor, J., Bopp, T., Vaeth, M., Klein, M., Serfling, E., Hunig, T., Becker, C., Schild, H. & Schmitt, E. 2012. Cyclic AMP underpins suppression by regulatory T cells. Eur J Immunol 42, 1375-1384.
9. Brooker, G., Harper, J.F., Terasaki, W.L. & Moylan, R.D. 1979. Radioimmunoassay of cyclic AMP and cyclic GMP. Adv Cyclic Nucleotide Res 10, 1-33.
10. Brown, K.M., Lee, L.C., Findlay, J.E., Day, J.P. & Baillie, G.S. 2012. Cyclic AMP-specific phosphodiesterase, PDE8A1, is activated by protein kinase A-mediated phosphorylation. FEBS Lett 586, 1631-1637.
11. Brudvik, K.W. & Tasken, K. 2012. Modulation of T cell immune functions by the prostaglandin E(2) - cAMP pathway in chronic inflammatory states. Br J Pharmacol 166, 411-419.
12. Brunton, L.L., Hayes, J.S. & Mayer, S.E. 1981. Functional compartmentation of cyclic AMP and protein kinase in heart. Adv Cyclic Nucleotide Res 14, 391-397.
13. Buxton, I.L. & Brunton, L.L. 1983. Compartments of cyclic AMP and protein kinase in mammalian cardiomyocytes. J Biol Chem 258, 10233-10239.
14. Calebiro, D., Nikolaev, V.O., Gagliani, M.C., de Filippis, T., Dees, C., Tacchetti, C., Persani, L. & Lohse, M.J. 2009. Persistent cAMP-signals triggered by internalized G-protein-coupled receptors. PLoS Biol 7, e1000172.
15. Carnegie, G.K., Soughayer, J., Smith, F.D., Pedroja, B.S., Zhang, F., Diviani, D., Bristow, M.R., Kunkel, M.T., Newton, A.C., Langeberg, L.K. & Scott, J.D. 2008. AKAP-Lbc mobilizes a cardiac hypertrophy signaling pathway. Mol Cell 32, 169-179.
16. Castro, L.R., Verde, I., Cooper, D.M. & Fischmeister, R. 2006. Cyclic guanosine monophosphate compartmentation in rat cardiac myocytes. Circulation 113, 2221-2228.
17. Chakir, K., Zhu, W., Tsang, S., Woo, A.Y., Yang, D., Wang, X., Zeng, X., Rhee, M.H., Mende, U., Koitabashi, N., Takimoto, E., Blumer, K.J., Lakatta, E.G., Kass, D.A. & Xiao, R.P. 2011. RGS2 is a primary terminator of beta(2)-adrenergic receptor-mediated G(i) signaling. J Mol Cell Cardiol 50, 1000-1007.
18. Chen, L., Marquardt, M.L., Tester, D.J., Sampson, K.J., Ackerman, M.J. & Kass, R.S. 2007. Mutation of an A-kinase-anchoring protein causes long-QT syndrome. Proc Natl Acad Sci USA 104, 20990-20995.
19. Communal, C., Singh, K., Sawyer, D.B. & Colucci, W.S. 1999. Opposing effects of beta(1)- and beta(2)-adrenergic receptors on cardiac myocyte apoptosis: role of a pertussis toxin-sensitive G protein. Circulation 100, 2210-2212.
20. Conti, M. & Beavo, J. 2007. Biochemistry and physiology of cyclic nucleotide phosphodiesterases: essential components in cyclic nucleotide signaling. Annu Rev Biochem 76, 481-511.
21. Di Benedetto, G., Zoccarato, A., Lissandron, V., Terrin, A., Li, X., Houslay, M.D., Baillie, G.S. & Zaccolo, M. 2008. Protein kinase A type I and type II define distinct intracellular signaling compartments. Circ Res 103, 836-844.
22. DiPilato, L.M., Cheng, X. & Zhang, J. 2004. Fluorescent indicators of cAMP and Epac activation reveal differential dynamics of cAMP signaling within discrete subcellular compartments. Proc Natl Acad Sci USA 101, 16513-16518.
23. Diviani, D., Dodge-Kafka, K.L., Li, J. & Kapiloff, M.S. 2011. A-kinase anchoring proteins: scaffolding proteins in the heart. Am J Physiol Heart Circ Physiol 301, H1742-H1753.
24. Dodge, K.L., Khouangsathiene, S., Kapiloff, M.S., Mouton, R., Hill, E.V., Houslay, M.D., Langeberg, L.K. & Scott, J.D. 2001. mAKAP assembles a protein kinase A/PDE4 phosphodiesterase cAMP signaling module. EMBO J 20, 1921-1930.
25. Dodge-Kafka, K.L., Langeberg, L. & Scott, J.D. 2006. Compartmentation of cyclic nucleotide signaling in the heart: the role of A-kinase anchoring proteins. Circ Res 98, 993-1001.
26. Dorn, G.W. II, Tepe, N.M., Lorenz, J.N., Koch, W.J. & Liggett, S.B. 1999. Low- and high-level transgenic expression of beta2-adrenergic receptors differentially affect cardiac hypertrophy and function in Galphaq-overexpressing mice. Proc Natl Acad Sci USA 96, 6400-6405.
27. Dunkern, T.R. & Hatzelmann, A. 2007. Characterization of inhibitors of phosphodiesterase 1C on a human cellular system. FEBS J 274, 4812-4824.
28. Edwards, H.V., Christian, F. & Baillie, G.S. 2012. cAMP: novel concepts in compartmentalised signalling. Semin Cell Dev Biol 23, 181-190.
29. Engelhardt, S., Hein, L., Wiesmann, F. & Lohse, M.J. 1999. Progressive hypertrophy and heart failure in beta1-adrenergic receptor transgenic mice. Proc Natl Acad Sci USA 96, 7059-7064.
30. Fischmeister, R., Castro, L.R., Abi-Gerges, A., Rochais, F., Jurevicius, J., Leroy, J. & Vandecasteele, G. 2006. Compartmentation of cyclic nucleotide signaling in the heart: the role of cyclic nucleotide phosphodiesterases. Circ Res 99, 816-828.
31. Ghigo, A., Perino, A., Mehel, H., Zahradnikova, A. Jr, Morello, F., Leroy, J., Nikolaev, V.O., Damilano, F., Cimino, J., De Luca, E. et al. 2012. PI3Kgamma Protects Against Catecholamine-Induced Ventricular Arrhythmia Through PKA-Mediated Regulation of Distinct Phosphodiesterases. Circulation 126, 2073-2083.
32. Gloerich, M. & Bos, J.L. 2010. Epac: defining a new mechanism for cAMP action. Annu Rev Pharmacol Toxicol 50, 355-375.
33. Han, P., Werber, J., Surana, M., Fleischer, N. & Michaeli, T. 1999. The calcium/calmodulin-dependent phosphodiesterase PDE1C down-regulates glucose-induced insulin secretion. J Biol Chem 274, 22337-22344.
34. Horackova, M. & Byczko, Z. 1997. Differences in the structural characteristics of adult guinea pig and rat cardiomyocytes during their adaptation and maintenance in long-term cultures: confocal microscopy study. Exp Cell Res 237, 158-175.
35. Houslay, M.D. & Adams, D.R. 2003. PDE4 cAMP phosphodiesterases: modular enzymes that orchestrate signalling cross-talk, desensitization and compartmentalization. Biochem J 370, 1-18.
36. Houslay, M.D., Baillie, G.S. & Maurice, D.H. 2007. cAMP-specific phosphodiesterase-4 enzymes in the cardiovascular system: a molecular toolbox for generating compartmentalized cAMP signaling. Circ Res 100, 950-966.
37. Hulme, J.T., Lin, T.W., Westenbroek, R.E., Scheuer, T. & Catterall, W.A. 2003. Beta-adrenergic regulation requires direct anchoring of PKA to cardiac CaV1.2 channels via a leucine zipper interaction with A kinase-anchoring protein 15. Proc Natl Acad Sci USA 100, 13093-13098.
38. Jiang, L.I., Collins, J., Davis, R., Lin, K.M., DeCamp, D., Roach, T., Hsueh, R., Rebres, R.A., Ross, E.M., Taussig, R., Fraser, I. & Sternweis, P.C. 2007. Use of a cAMP BRET sensor to characterize a novel regulation of cAMP by the sphingosine 1-phosphate/G13 pathway. J Biol Chem 282, 10576-10584.
39. Jurevicius, J. & Fischmeister, R. 1996. cAMP compartmentation is responsible for a local activation of cardiac Ca2+ channels by beta-adrenergic agonists. Proc Natl Acad Sci USA 93, 295-299.
40. Kabaeva, Z., Zhao, M. & Michele, D.E. 2008. Blebbistatin extends culture life of adult mouse cardiac myocytes and allows efficient and stable transgene expression. Am J Physiol Heart Circ Physiol 294, H1667-H1674.
41. Kandel, E.R. 2001. The molecular biology of memory storage: a dialogue between genes and synapses. Science 294, 1030-1038.
42. Kashimura, T., Briston, S.J., Trafford, A.W., Napolitano, C., Priori, S.G., Eisner, D.A. & Venetucci, L.A. 2010. In the RyR2(R4496C) mouse model of CPVT, beta-adrenergic stimulation induces Ca waves by increasing SR Ca content and not by decreasing the threshold for Ca waves. Circ Res 107, 1483-1489.
43. Kawasaki, H., Springett, G.M., Mochizuki, N., Toki, S., Nakaya, M., Matsuda, M., Housman, D.E. & Graybiel, A.M. 1998. A family of cAMP-binding proteins that directly activate Rap1. Science 282, 2275-2279.
44. Kerfant, B.G., Zhao, D., Lorenzen-Schmidt, I., Wilson, L.S., Cai, S., Chen, S.R., Maurice, D.H. & Backx, P.H. 2007. PI3Kgamma is required for PDE4, not PDE3, activity in subcellular microdomains containing the sarcoplasmic reticular calcium ATPase in cardiomyocytes. Circ Res 101, 400-408.
45. Kirshenbaum, L.A., MacLellan, W.R., Mazur, W., French, B.A. & Schneider, M.D. 1993. Highly efficient gene transfer into adult ventricular myocytes by recombinant adenovirus. J Clin Invest 92, 381-387.
46. Kostic, M.M., Erdogan, S., Rena, G., Borchert, G., Hoch, B., Bartel, S., Scotland, G., Huston, E., Houslay, M.D. & Krause, E.G. 1997. Altered expression of PDE1 and PDE4 cyclic nucleotide phosphodiesterase isoforms in 7-oxo-prostacyclin-preconditioned rat heart. J Mol Cell Cardiol 29, 3135-3146.
47. Kuschel, M., Zhou, Y.Y., Spurgeon, H.A., Bartel, S., Karczewski, P., Zhang, S.J., Krause, E.G., Lakatta, E.G. & Xiao, R.P. 1999. beta2-adrenergic cAMP signaling is uncoupled from phosphorylation of cytoplasmic proteins in canine heart. Circulation 99, 2458-2465.
48. Leech, C.A., Chepurny, O.G. & Holz, G.G. 2010. Epac2-dependent rap1 activation and the control of islet insulin secretion by glucagon-like peptide-1. Vitam Horm 84, 279-302.
49. Lehnart, S.E., Wehrens, X.H., Reiken, S., Warrier, S., Belevych, A.E., Harvey, R.D., Richter, W., Jin, S.L., Conti, M. & Marks, A.R. 2005. Phosphodiesterase 4D deficiency in the ryanodine-receptor complex promotes heart failure and arrhythmias. Cell 123, 25-35.
50. Leroy, J., Richter, W., Mika, D., Castro, L.R., Abi-Gerges, A., Xie, M., Scheitrum, C., Lefebvre, F., Schittl, J., Mateo, P. et al. 2011. Phosphodiesterase 4B in the cardiac L-type Ca(2)(+) channel complex regulates Ca(2)(+) current and protects against ventricular arrhythmias in mice. J Clin Invest 121, 2651-2661.
51. Li, Y., Chen, L., Kass, R.S. & Dessauer, C.W. 2012. The A-kinase anchoring protein yotiao facilitates complex formation between adenylyl cyclase type 9 and the IKs potassium channel in heart. J Biol Chem 287, 29815-29824.
52. Liu, R., Ramani, B., Soto, D., De Arcangelis, V. & Xiang, Y. 2009. Agonist dose-dependent phosphorylation by protein kinase A and G protein-coupled receptor kinase regulates beta2 adrenoceptor coupling to G(i) proteins in cardiomyocytes. J Biol Chem 284, 32279-32287.
53. Lohse, M.J., Engelhardt, S. & Eschenhagen, T. 2003. What is the role of beta-adrenergic signaling in heart failure? Circ Res 93, 896-906.
54. Lompre, A.M., Hajjar, R.J., Harding, S.E., Kranias, E.G., Lohse, M.J. & Marks, A.R. 2010. Ca2+ cycling and new therapeutic approaches for heart failure. Circulation 121, 822-830.
55. Lygren, B., Carlson, C.R., Santamaria, K., Lissandron, V., McSorley, T., Litzenberg, J., Lorenz, D., Wiesner, B., Rosenthal, W., Zaccolo, M., Tasken, K. & Klussmann, E. 2007. AKAP complex regulates Ca2+ re-uptake into heart sarcoplasmic reticulum. EMBO Rep 8, 1061-1067.
56. Maier, L.S., Bers, D.M. & Brown, J.H. 2007. Calmodulin and Ca2+/calmodulin kinases in the heart - physiology and pathophysiology. Cardiovasc Res 73, 629-630.
57. Mangmool, S., Shukla, A.K. & Rockman, H.A. 2010. beta-Arrestin-dependent activation of Ca(2+)/calmodulin kinase II after beta(1)-adrenergic receptor stimulation. J Cell Biol 189, 573-587.
58. Martinez, S.E., Wu, A.Y., Glavas, N.A., Tang, X.B., Turley, S., Hol, W.G. & Beavo, J.A. 2002. The two GAF domains in phosphodiesterase 2A have distinct roles in dimerization and in cGMP binding. Proc Natl Acad Sci USA 99, 13260-13265.
59. Marx, S.O., Reiken, S., Hisamatsu, Y., Jayaraman, T., Burkhoff, D., Rosemblit, N. & Marks, A.R. 2000. PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts. Cell 101, 365-376.
60. Marx, S.O., Kurokawa, J., Reiken, S., Motoike, H., D'Armiento, J., Marks, A.R. & Kass, R.S. 2002. Requirement of a macromolecular signaling complex for beta adrenergic receptor modulation of the KCNQ1-KCNE1 potassium channel. Science 295, 496-499.
61. Matthiesen, K. & Nielsen, J. 2011. Cyclic AMP control measured in two compartments in HEK293 cells: phosphodiesterase K(M) is more important than phosphodiesterase localization. PLoS ONE 6, e24392.
62. Mauban, J.R., O'Donnell, M., Warrier, S., Manni, S. & Bond, M. 2009. AKAP-scaffolding proteins and regulation of cardiac physiology. Physiology (Bethesda) 24, 78-87.
63. Metrich, M., Lucas, A., Gastineau, M., Samuel, J.L., Heymes, C., Morel, E. & Lezoualc'h, F. 2008. Epac mediates beta-adrenergic receptor-induced cardiomyocyte hypertrophy. Circ Res 102, 959-965.
64. Michel, M.C., Maisel, A.S. & Brodde, O.E. 1990. Mitigation of beta 1- and/or beta 2-adrenoceptor function in human heart failure. Br J Clin Pharmacol 30(Suppl 1), 37S-42S.
65. Milano, C.A., Allen, L.F., Rockman, H.A., Dolber, P.C., McMinn, T.R., Chien, K.R., Johnson, T.D., Bond, R.A. & Lefkowitz, R.J. 1994. Enhanced myocardial function in transgenic mice overexpressing the beta 2-adrenergic receptor. Science 264, 582-586.
66. Miller, C.L. & Yan, C. 2010. Targeting cyclic nucleotide phosphodiesterase in the heart: therapeutic implications. J Cardiovasc Transl Res 3, 507-515.
67. Miller, C.L., Oikawa, M., Cai, Y., Wojtovich, A.P., Nagel, D.J., Xu, X., Xu, H., Florio, V., Rybalkin, S.D., Beavo, J.A., Chen, Y.F., Li, J.D., Blaxall, B.C., Abe, J. & Yan, C. 2009. Role of Ca2+/calmodulin-stimulated cyclic nucleotide phosphodiesterase 1 in mediating cardiomyocyte hypertrophy. Circ Res 105, 956-964.
68. Molina, C.E., Leroy, J., Richter, W., Xie, M., Scheitrum, C., Lee, I.O., Maack, C., Rucker-Martin, C., Donzeau-Gouge, P., Verde, I., Llach, A., Hove-Madsen, L., Conti, M., Vandecasteele, G. & Fischmeister, R. 2012. Cyclic adenosine monophosphate phosphodiesterase type 4 protects against atrial arrhythmias. J Am Coll Cardiol 59, 2182-2190.
69. Mongillo, M., Tocchetti, C.G., Terrin, A., Lissandron, V., Cheung, Y.F., Dostmann, W.R., Pozzan, T., Kass, D.A., Paolocci, N., Houslay, M.D. & Zaccolo, M. 2006. Compartmentalized phosphodiesterase-2 activity blunts beta-adrenergic cardiac inotropy via an NO/cGMP-dependent pathway. Circ Res 98, 226-234.
70. Morgado, M., Cairrao, E., Santos-Silva, A.J. & Verde, I. 2012. Cyclic nucleotide-dependent relaxation pathways in vascular smooth muscle. Cell Mol Life Sci 69, 247-266.
71. Nagel, D.J., Aizawa, T., Jeon, K.I., Liu, W., Mohan, A., Wei, H., Miano, J.M., Florio, V.A., Gao, P., Korshunov, V.A., Berk, B.C. & Yan, C. 2006. Role of nuclear Ca2+/calmodulin-stimulated phosphodiesterase 1A in vascular smooth muscle cell growth and survival. Circ Res 98, 777-784.
72. Neef, S., Dybkova, N., Sossalla, S., Ort, K.R., Fluschnik, N., Neumann, K., Seipelt, R., Schondube, F.A., Hasenfuss, G. & Maier, L.S. 2010. CaMKII-dependent diastolic SR Ca2+ leak and elevated diastolic Ca2+ levels in right atrial myocardium of patients with atrial fibrillation. Circ Res 106, 1134-1144.
73. Nichols, C.B., Rossow, C.F., Navedo, M.F., Westenbroek, R.E., Catterall, W.A., Santana, L.F. & McKnight, G.S. 2010. Sympathetic stimulation of adult cardiomyocytes requires association of AKAP5 with a subpopulation of L-type calcium channels. Circ Res 107, 747-756.
74. Nikolaev, V.O. & Lohse, M.J. 2006. Monitoring of cAMP synthesis and degradation in living cells. Physiology (Bethesda) 21, 86-92.
75. Nikolaev, V.O., Bunemann, M., Hein, L., Hannawacker, A. & Lohse, M.J. 2004. Novel single chain cAMP sensors for receptor-induced signal propagation. J Biol Chem 279, 37215-37218.
76. Nikolaev, V.O., Bunemann, M., Schmitteckert, E., Lohse, M.J. & Engelhardt, S. 2006. Cyclic AMP imaging in adult cardiac myocytes reveals far-reaching beta1-adrenergic but locally confined beta2-adrenergic receptor-mediated signaling. Circ Res 99, 1084-1091.
77. Nikolaev, V.O., Moshkov, A., Lyon, A.R., Miragoli, M., Novak, P., Paur, H., Lohse, M.J., Korchev, Y.E., Harding, S.E. & Gorelik, J. 2010. Beta2-adrenergic receptor redistribution in heart failure changes cAMP compartmentation. Science 327, 1653-1657.
78. Novak, P., Li, C., Shevchuk, A.I., Stepanyan, R., Caldwell, M., Hughes, S., Smart, T.G., Gorelik, J., Ostanin, V.P., Lab, M.J., Moss, G.W., Frolenkov, G.I., Klenerman, D. & Korchev, Y.E. 2009. Nanoscale live-cell imaging using hopping probe ion conductance microscopy. Nat Methods 6, 279-281.
79. Osadchii, O.E. 2007. Myocardial phosphodiesterases and regulation of cardiac contractility in health and cardiac disease. Cardiovasc Drugs Ther 21, 171-194.
80. Pare, G.C., Bauman, A.L., McHenry, M., Michel, J.J., Dodge-Kafka, K.L. & Kapiloff, M.S. 2005. The mAKAP complex participates in the induction of cardiac myocyte hypertrophy by adrenergic receptor signaling. J Cell Sci 118, 5637-5646.
81. Patrucco, E., Notte, A., Barberis, L., Selvetella, G., Maffei, A., Brancaccio, M., Marengo, S., Russo, G., Azzolino, O., Rybalkin, S.D. et al. 2004. PI3Kgamma modulates the cardiac response to chronic pressure overload by distinct kinase-dependent and -independent effects. Cell 118, 375-387.
82. Patrucco, E., Albergine, M.S., Santana, L.F. & Beavo, J.A. 2010. Phosphodiesterase 8A (PDE8A) regulates excitation-contraction coupling in ventricular myocytes. J Mol Cell Cardiol 49, 330-333.
83. Patterson, A.J., Zhu, W., Chow, A., Agrawal, R., Kosek, J., Xiao, R.P. & Kobilka, B. 2004. Protecting the myocardium: a role for the beta2 adrenergic receptor in the heart. Crit Care Med 32, 1041-1048.
84. Perino, A., Ghigo, A., Scott, J.D. & Hirsch, E. 2012. Anchoring proteins as regulators of signaling pathways. Circ Res 111, 482-492.
85. Ponsioen, B., Zhao, J., Riedl, J., Zwartkruis, F., van der Krogt, G., Zaccolo, M., Moolenaar, W.H., Bos, J.L. & Jalink, K. 2004. Detecting cAMP-induced Epac activation by fluorescence resonance energy transfer: Epac as a novel cAMP indicator. EMBO Rep 5, 1176-1180.
86. Rich, T.C., Fagan, K.A., Tse, T.E., Schaack, J., Cooper, D.M. & Karpen, J.W. 2001. A uniform extracellular stimulus triggers distinct cAMP signals in different compartments of a simple cell. Proc Natl Acad Sci USA 98, 13049-13054.
87. Richter, W., Day, P., Agrawal, R., Bruss, M.D., Granier, S., Wang, Y.L., Rasmussen, S.G., Horner, K., Wang, P., Lei, T., Patterson, A.J., Kobilka, B. & Conti, M. 2008. Signaling from beta1- and beta2-adrenergic receptors is defined by differential interactions with PDE4. EMBO J 27, 384-393.
88. Richter, W., Xie, M., Scheitrum, C., Krall, J., Movsesian, M.A. & Conti, M. 2011. Conserved expression and functions of PDE4 in rodent and human heart. Basic Res Cardiol 106, 249-262.
89. Rochais, F., Vandecasteele, G., Lefebvre, F., Lugnier, C., Lum, H., Mazet, J.L., Cooper, D.M. & Fischmeister, R. 2004. Negative feedback exerted by cAMP-dependent protein kinase and cAMP phosphodiesterase on subsarcolemmal cAMP signals in intact cardiac myocytes: an in vivo study using adenovirus-mediated expression of CNG channels. J Biol Chem 279, 52095-52105.
90. Ruiz-Hurtado, G., Morel, E., Dominguez-Rodriguez, A., Llach, A., Lezoualc'h, F., Benitah, J.P. & Gomez, A.M. 2012. Epac in cardiac calcium signaling. J Mol Cell Cardiol. doi: 10.1016/j.yjmcc.2012.11.021.
91. Rybalkin, S.D., Rybalkina, I., Beavo, J.A. & Bornfeldt, K.E. 2002. Cyclic nucleotide phosphodiesterase 1C promotes human arterial smooth muscle cell proliferation. Circ Res 90, 151-157.
92. Sarkar, D., Erlichman, J. & Rubin, C.S. 1984. Identification of a calmodulin-binding protein that co-purifies with the regulatory subunit of brain protein kinase II. J Biol Chem 259, 9840-9846.
93. Scott, J.D. & Santana, L.F. 2010. A-kinase anchoring proteins: getting to the heart of the matter. Circulation 121, 1264-1271.
94. Scott, J.D., Dessauer, C.W. & Tasken, K. 2013. Creating order from chaos: cellular regulation by kinase anchoring. Annu Rev Pharmacol Toxicol 53, 187-210.
95. Shan, J., Betzenhauser, M.J., Kushnir, A., Reiken, S., Meli, A.C., Wronska, A., Dura, M., Chen, B.X. & Marks, A.R. 2010a. Role of chronic ryanodine receptor phosphorylation in heart failure and beta-adrenergic receptor blockade in mice. J Clin Invest 120, 4375-4387.
96. Shan, J., Kushnir, A., Betzenhauser, M.J., Reiken, S., Li, J., Lehnart, S.E., Lindegger, N., Mongillo, M., Mohler, P.J. & Marks, A.R. 2010b. Phosphorylation of the ryanodine receptor mediates the cardiac fight or flight response in mice. J Clin Invest 120, 4388-4398.
97. Sin, Y.Y., Edwards, H.V., Li, X., Day, J.P., Christian, F., Dunlop, A.J., Adams, D.R., Zaccolo, M., Houslay, M.D. & Baillie, G.S. 2011. Disruption of the cyclic AMP phosphodiesterase-4 (PDE4)-HSP20 complex attenuates the beta-agonist induced hypertrophic response in cardiac myocytes. J Mol Cell Cardiol 50, 872-883.
98. Soderling, S.H., Bayuga, S.J. & Beavo, J.A. 1998. Cloning and characterization of a cAMP-specific cyclic nucleotide phosphodiesterase. Proc Natl Acad Sci USA 95, 8991-8996.
99. Soltis, A.R. & Saucerman, J.J. 2010. Synergy between CaMKII substrates and beta-adrenergic signaling in regulation of cardiac myocyte Ca(2+) handling. Biophys J 99, 2038-2047.
100. Sonnenburg, W.K., Seger, D. & Beavo, J.A. 1993. Molecular cloning of a cDNA encoding the "61-kDa" calmodulin-stimulated cyclic nucleotide phosphodiesterase. Tissue-specific expression of structurally related isoforms. J Biol Chem 268, 645-652.
101. Stangherlin, A., Gesellchen, F., Zoccarato, A., Terrin, A., Fields, L.A., Berrera, M., Surdo, N.C., Craig, M.A., Smith, G., Hamilton, G. & Zaccolo, M. 2011. cGMP signals modulate cAMP levels in a compartment-specific manner to regulate catecholamine-dependent signaling in cardiac myocytes. Circ Res 108, 929-939.
102. Strang, K.T., Sweitzer, N.K., Greaser, M.L. & Moss, R.L. 1994. Beta-adrenergic receptor stimulation increases unloaded shortening velocity of skinned single ventricular myocytes from rats. Circ Res 74, 542-549.
103. Tengholm, A. & Gylfe, E. 2009. Oscillatory control of insulin secretion. Mol Cell Endocrinol 297, 58-72.
104. Troger, J., Moutty, M.C., Skroblin, P. & Klussmann, E. 2012. A-kinase anchoring proteins as potential drug targets. Br J Pharmacol 166, 420-433.
105. Vila Petroff, M.G., Egan, J.M., Wang, X. & Sollott, S.J. 2001. Glucagon-like peptide-1 increases cAMP but fails to augment contraction in adult rat cardiac myocytes. Circ Res 89, 445-452.
106. Wechsler, J., Choi, Y.H., Krall, J., Ahmad, F., Manganiello, V.C. & Movsesian, M.A. 2002. Isoforms of cyclic nucleotide phosphodiesterase PDE3A in cardiac myocytes. J Biol Chem 277, 38072-38078.
107. Wehrens, X.H., Lehnart, S.E., Huang, F., Vest, J.A., Reiken, S.R., Mohler, P.J., Sun, J., Guatimosim, S., Song, L.S., Rosemblit, N. et al. 2003. FKBP12.6 deficiency and defective calcium release channel (ryanodine receptor) function linked to exercise-induced sudden cardiac death. Cell 113, 829-840.
108. Wehrens, X.H., Lehnart, S.E., Reiken, S., Vest, J.A., Wronska, A. & Marks, A.R. 2006. Ryanodine receptor/calcium release channel PKA phosphorylation: a critical mediator of heart failure progression. Proc Natl Acad Sci USA 103, 511-518.
109. Weishaar, R.E., Kobylarz-Singer, D.C. & Kaplan, H.R. 1987. Subclasses of cyclic AMP phosphodiesterase in cardiac muscle. J Mol Cell Cardiol 19, 1025-1036.
110. Williams, C. 2004. cAMP detection methods in HTS: selecting the best from the rest. Nat Rev Drug Discov 3, 125-135.
111. Willoughby, D. & Cooper, D.M. 2008. Live-cell imaging of cAMP dynamics. Nat Methods 5, 29-36.
112. Xiang, Y.K. 2011. Compartmentalization of beta-adrenergic signals in cardiomyocytes. Circ Res 109, 231-244.
113. Xiao, R.P. 2001. Beta-adrenergic signaling in the heart: dual coupling of the beta2-adrenergic receptor to G(s) and G(i) proteins. Sci STKE 2001, re15.
114. Zaccolo, M. 2009. cAMP signal transduction in the heart: understanding spatial control for the development of novel therapeutic strategies. Br J Pharmacol 158, 50-60.
115. Zaccolo, M. 2011. Spatial control of cAMP signalling in health and disease. Curr Opin Pharmacol 11, 649-655.
116. Zaccolo, M. & Movsesian, M.A. 2007. cAMP and cGMP signaling cross-talk: role of phosphodiesterases and implications for cardiac pathophysiology. Circ Res 100, 1569-1578.
117. Zaccolo, M. & Pozzan, T. 2002. Discrete microdomains with high concentration of cAMP in stimulated rat neonatal cardiac myocytes. Science 295, 1711-1715.
118. Zakhary, D.R., Moravec, C.S. & Bond, M. 2000. Regulation of PKA binding to AKAPs in the heart: alterations in human heart failure. Circulation 101, 1459-1464.
119. Zhang, X., Szeto, C., Gao, E., Tang, M., Jin, J., Fu, Q., Makarewich, C., Ai, X., Li, Y., Tang, A. et al. 2012. Cardiotoxic and cardioprotective features of chronic beta-adrenergic signaling. Circ Res 112, 498-509.